Taki Chemical Co., Ltd. (TYO:4025)
Japan · Delayed Price · Currency is JPY 6,060.00
+50.00 (0.83%)
Aug 27, 2026, 2:09 PM JST
Taki Chemical Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 44,497 | 41,977 | 38,916 | 34,852 | 35,846 | 32,812 | |
Revenue Growth | 10.24% | 7.87% | 11.66% | -2.77% | 9.25% | 8.74% |
Cost of Revenue | 33,385 | 31,735 | 29,908 | 27,922 | 27,040 | 24,247 |
Gross Profit | 11,112 | 10,242 | 9,008 | 6,930 | 8,806 | 8,565 |
Selling, General & Admin | 6,509 | 6,194 | 5,639 | 5,372 | 5,401 | 5,353 |
Research & Development | 553 | 553 | 427 | 486 | 497 | 461 |
Operating Expenses | 7,391 | 7,078 | 6,339 | 6,016 | 6,053 | 5,906 |
Operating Income | 3,721 | 3,164 | 2,669 | 914 | 2,753 | 2,659 |
Interest Expense | -18 | -16 | -12 | -11 | -12 | -12 |
Interest & Investment Income | 632 | 587 | 425 | 379 | 339 | 279 |
Currency Exchange Gain (Loss) | 14 | - | - | - | - | - |
Other Non Operating Income (Expenses) | 46 | 44 | 80 | 57 | 47 | 85 |
EBT Excluding Unusual Items | 4,395 | 3,779 | 3,162 | 1,339 | 3,127 | 3,011 |
Gain (Loss) on Sale of Investments | 682 | 682 | 35 | 428 | 65 | -3 |
Gain (Loss) on Sale of Assets | -4 | 5 | 92 | -25 | -28 | -19 |
Asset Writedown | -72 | -93 | -52 | - | -124 | -309 |
Other Unusual Items | 4 | -1 | 25 | 214 | -2 | -1 |
Pretax Income | 5,005 | 4,372 | 3,262 | 1,956 | 3,038 | 2,679 |
Income Tax Expense | 1,232 | 1,081 | 964 | 628 | 1,015 | 763 |
Earnings From Continuing Operations | 3,773 | 3,291 | 2,298 | 1,328 | 2,023 | 1,916 |
Minority Interest in Earnings | -28 | -14 | 1 | 28 | 33 | - |
Net Income | 3,745 | 3,277 | 2,299 | 1,356 | 2,056 | 1,916 |
Net Income to Common | 3,745 | 3,277 | 2,299 | 1,356 | 2,056 | 1,916 |
Net Income Growth | 39.48% | 42.54% | 69.54% | -34.05% | 7.31% | 22.90% |
Shares Outstanding (Basic) | 8 | 8 | 8 | 9 | 9 | 9 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 9 | 9 | 9 |
Shares Change | -1.47% | -0.58% | -2.02% | -0.10% | 0.07% | 0.07% |
EPS (Basic) | 448.26 | 389.01 | 271.33 | 156.80 | 237.50 | 221.48 |
EPS (Diluted) | 448.26 | 389.01 | 271.33 | 156.80 | 237.50 | 221.48 |
EPS Growth | 41.56% | 43.37% | 73.04% | -33.98% | 7.23% | 22.81% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 3,202 | 748 | 2,534 | -529 | -34 | 218 |
Free Cash Flow Per Share | 383.27 | 88.79 | 299.07 | -61.17 | -3.93 | 25.20 |
Dividend Per Share | 60.000 | 60.000 | 50.000 | 45.000 | 45.000 | 45.000 |
Dividend Growth | 20.00% | 20.00% | 11.11% | 0% | 0% | 0% |
Gross Margin | 24.97% | 24.40% | 23.15% | 19.88% | 24.57% | 26.10% |
Operating Margin | 8.36% | 7.54% | 6.86% | 2.62% | 7.68% | 8.10% |
Profit Margin | 8.42% | 7.81% | 5.91% | 3.89% | 5.74% | 5.84% |
Free Cash Flow Margin | 7.20% | 1.78% | 6.51% | -1.52% | -0.10% | 0.66% |
EBITDA | 5,173 | 4,532 | 3,913 | 2,061 | 4,034 | 3,847 |
EBITDA Margin | 11.63% | 10.80% | 10.05% | 5.91% | 11.25% | 11.72% |
D&A For EBITDA | 1,452 | 1,368 | 1,244 | 1,147 | 1,281 | 1,188 |
EBIT | 3,721 | 3,164 | 2,669 | 914 | 2,753 | 2,659 |
EBIT Margin | 8.36% | 7.54% | 6.86% | 2.62% | 7.68% | 8.10% |
Effective Tax Rate | 24.62% | 24.73% | 29.55% | 32.11% | 33.41% | 28.48% |